- Description
CSB VLPs: Our virus-like particles display FULL-LENGTH membrane proteins in a NATIVE mammalian lipid bilayer, preserving the conformational structure. Each preparation is SPECIFIC to your target, providing a stable antigen for immunization, display selection, screening, and SPR/BLI characterization.
| Target | VIPR2 |
| Target Aliases | C16DUPq36.3, DUP7q36.3, PACAP-R-3, PACAP-R3, VIP-R-2, VPAC2, VPAC2R, VPCAP2R |
Stable for 12 months from date of receipt at -80°C or lower. Avoid repeated freeze-thaw cycles.
Vasoactive intestinal polypeptide receptor 2 (VIPR2) is a G-protein coupled receptor primarily involved in mediating the effects of vasoactive intestinal peptide (VIP) and pituitary adenylate cyclase-activating polypeptide (PACAP). This receptor plays a critical role in smooth muscle relaxation, secretion of electrolytes, and modulation of immune responses. VIPR2 is expressed in various tissues, including the central nervous system and immune cells, making it a key target in research related to neuroendocrine and immune system functions. Other names: C16DUPq36.3, DUP7q36.3, PACAP-R-3, PACAP-R3, VIP-R-2, VPAC2, VPAC2R, VPCAP2R For more details, see: - [NCBI Gene: 7434 (Human)](https://www.ncbi.nlm.nih.gov/gene/7434) - [UniProt: P41587 (Human)](https://www.uniprot.org/uniprot/P41587) - [Human Protein Atlas: No entry available] - [GeneCards: VIPR2 (Human)](https://www.genecards.org/cgi-bin/carddisp.pl?gene=VIPR2) - [Ensembl Gene: ENSG00000185499 (Human)](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000185499)
